Ongoing Projects

There are a number of research studies and clinical collaborations which are active or under development. Please click on the links below for further information.

  • Research study: Skin Cancers in Chronic Lymphocytic Leukaemia (CLL)
    A national multicenter retrospective analysis of patients with co-existing diagnoses of cutaneous melanoma and CLL.

  • Research study: MyMelanoma
    A large cohort study which aims to recruit at least 20,000 participants who have been treated by the NHS for melanoma of the skin and other body sites

  • Consensus Statement Development Group:
    A national, multidisciplinary working party to establish UK expert Consensus Guidelines on Skin Surveillance for Solid Organ Transplants. Chaired by: Dr Tanya Basu. Contact details: TBC.

  • Management of skin toxicities and checkpoint inhibitors and the Guidelines Development Group with Melanoma Focus
    Melanoma Charity for Professionals, Patients and Public – Melanoma Focus:
    A national guidelines development group (including Dr Louise Fearfield, Dr Catherine Harwood and Dr Rubeta Matin, BSSCII) is developing guidelines for skin toxicity management associated with checkpoint inhibitors, with Melanoma Focus. Chaired by: Dr Andrew Muinonen-Martin, Leeds who presented the outline of the guidelines at last year’s BSSCII meeting. The final draft guidelines are due to be presented at the October meeting of Melanoma Focus. Dr Louise Fearfield is also giving a talk at this year’s BSSCII meeting on the practical aspects of managing toxicities associated with checkpoint inhibitors based on her recent publication in the British Journal of Dermatology How to recognize and manage skin toxicities associated with immune checkpoint inhibitors: a practical approach – PubMed (nih.gov)